Edition:
United States

Profile: Ventripoint Diagnostics Ltd (VPT.V)

VPT.V on TSX Venture Exchange

0.17CAD
21 Jul 2016
Change (% chg)

-- (--)
Prev Close
$0.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,603
52-wk High
$0.70
52-wk Low
$0.12

Ventripoint Diagnostics Ltd., formerly Luca Capital Inc., is a medical device company. The Company is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. By using images produced from existing medical imaging systems, the Ventripoint Medical System (VMS) generates accurate heart volumetric measurements and a three-dimensional (3D) model in a rapid and inexpensive manner. The Company's solution produces critical heart information by processing standard information received from existing medical imaging equipment with its methods incorporating Knowledge Based Reconstruction (KBR) algorithms and cardiac databases (catalogues). Its technology platform is applicable to all heart diseases. The Company has developed prototype analytical software package to be used with 4D echocardiograms (VMS-4DE) and one to be used with magnetic resonance imaging (MRI) images (VMS-CMR). It also focuses on developing VMS-Plus and the VMS-Nano.

Company Address

Ventripoint Diagnostics Ltd

100 W Harrison St Ste 410
SEATTLE   WA   98119-4116
P: +1206.2830221
F: +1425.7474163

Company Web Links